FEATURED STORIES

Could Gluten Literally Drive You Insane? Going Back 60 Years…

Despite much progression towards a free, individualistic society, a considerable amount of conformity unfortunately remains. This results in bullying and harassment towards people who simply make different choices or have different needs, even it is simply what is best for their health. In this case, the “different” ones are those who need to stay on a gluten-free diet.

Exercise in Old Age Essential for Reducing Disability, Regaining Independence

A new study suggests that you’re never too old to get moving, showcasing how exercise can help improve memory and reverse muscle loss in older adults – ultimately helping them to recover from disability and regain independence.
Dr. Thomas Gill, a professor medicine at Yale University School of Medicine, and a team of colleagues followed more than 1,600 elderly adults who were mostly sedentary at the beginning of the study. [1]

A Village Full of Centenarians Shares Secrets to Longevity

Acciaroli, Italy is known for two things: its stunning seaside beauty and the fact that 1 in 10 people who inhabit the village are classed as centenarians – someone who lives to be 100 years old or more. Eighty-one of its 7,000 citizens are over 100, not to mention a large population of those living healthily in their 80’s and 90’s.
Drawn to understand the secret of their longevity, scientists at Rome’s Sapienza University and the San Diego School of Medicine spent 6 months studying the locals and unveiled their findings at a conference in the village. [1]

In States that Legalize Medical Marijuana, Opioid Use Decreases

A study published on September 15 shows that in states where medical marijuana is legal, fewer people use opioid drugs, bolstering advocates’ claims that marijuana can substitute for more deadly substances. [1]
Researchers examined federal traffic safety data from 1999 to 2013, using a sample of more than 68,000 people who died in a car crash in 18 states.

Marijuana-Based Drug Nears Approval for Childhood Epilepsy

On September 26, a marijuana-based childhood epilepsy drug took a step closer to winning approval when its maker announced promising phase 3 clinical trial results. [1]
Justin Gover, CEO of the British biotech company GW Pharmaceuticals, said that the children participating in the trial had previously tried 10 other anti-epileptic drugs. Despite using the medication, the young participants still experienced 3 seizures a day, approximately 90 a month. Said Gover: